Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

shutterstock_124071745_resized for site2016 Full Year Financial Results

Genmab published its 2016 Full Year financial results and held an investor conference call on February 22. Click here to listen to the archived webcast. Click here to view the report. Click here to view the presentation. Click here to view the 2016 summary in Danish. Click here to download the podcast. 

Annual General Meeting 2017

Genmab's Annual General Meeting will be held on Tuesday, March 28, 2017 at 2 PM CEST in Copenhagen, Denmark. Please click here for more information in Danish or in English


 

InvestorPortal

To register your email address for electronic shareholder communications to update your settings, log on to the InvestorPortal